About Hojabr Alimi
Hojabr Alimi is CEO and director at Spectrum Antimicrobials.
Hojabr Alimi reports to the SEC as a director or officer of 2 public companies: Pulmatrix (PULM) and Sonoma Pharmaceuticals (SNOA).
Hojabr Alimi first appears on SEC filings in 2007.
Experience
This experience comes from SEC filings. The years are when the filings name Hojabr Alimi in the role, so the role may have started earlier or lasted longer.
Spectrum Antimicrobials, Inc.
CEO and director
2020 – 2026 · Petaluma, CA
Develops infection-control products for healthcare providers.
PI
Pulmatrix, Inc.
CEO and Chief Science Officer, director
2014 · Public company (PULM)
SI
Sonoma Pharmaceuticals, Inc.
Chief Executive Officer and director
2007 – 2012 · Public company (SNOA)
Key Colleagues at Startups
The people Hojabr Alimi works with at each company, as listed on that company's latest Form D.
Spectrum Antimicrobials, Inc. · Form D/A, Apr 1, 2026
KL
Kate Lewis
Director
DA
David Allie
Director
SS
Steven Solferino
Director
WI
William Watson III
Executive officer, director and promoter
JS
Jerry Stonemetz
Executive officer